Lars Beckmann
Koeln, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Correction: Performance of several types of beta-binomial models in comparison to standard approaches for meta-analyses with very few studies.
Journal: BMC medical research methodology
Published: February 17, 2026
Hazards, Causality, and Practical Relevance of Collider Effects - Comment on Beyersmann et al. "Hazards Constitute Key Quantities for Analyzing, Interpreting and Understanding Time-to-Event Data".
Journal: Biometrical journal. Biometrische Zeitschrift
Published: May 13, 2025
Performance of several types of beta-binomial models in comparison to standard approaches for meta-analyses with very few studies.
Journal: BMC medical research methodology
Published: May 31, 2022
Diagnostic accuracy of rapid point-of-care tests for diagnosis of current SARS-CoV-2 infections in children: a systematic review and meta-analysis.
Journal: BMJ evidence-based medicine
Published: December 13, 2021
Limitations of the incidence density ratio as approximation of the hazard ratio.
Journal: Trials
Published: March 27, 2019
Contribution to the discussion of "When should meta-analysis avoid making hidden normality assumptions?"
Journal: Biometrical journal. Biometrische Zeitschrift
Published: June 28, 2018
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.
Journal: Nature communications
Published: April 16, 2015
Biometrical issues in the analysis of adverse events within the benefit assessment of drugs.
Journal: Pharmaceutical statistics
Published: April 07, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Journal: Gynecologic oncology
Published: March 09, 2015
Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.
Journal: Human molecular genetics
Published: August 30, 2014
A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: February 05, 2014
Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.
Journal: Endocrine-related cancer
Published: October 02, 2013
Last Updated: 09/26/2026